A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related MyocarditisNovel Teaching Points

A Case of Lung Cancer with Very-Late-Onset Immune Checkpoint Inhibitor-Related MyocarditisNovel Teaching Points

Immune checkpoint inhibitor (ICI)-related myocarditis has been reported to appear in the early phase after ICI initiation. Herein, we report the case of a 78-year-old man with non-small cell lung cancer. Pembrolizumab was introduced as first-line therapy. After 9 months, second-line therapy, includi...

Full description

Bibliographic Details
Main Authors: Tatsuya Nishikawa, MD, PhD, Motohiro Tamiya, MD, PhD, Keiko Ohta-Ogo, MD, PhD, Yoshihiko Ikeda, MD, PhD, Kinta Hatakeyama, MD, PhD, Keiichiro Honma, MD, PhD, Taku Yasui, MD, PhD, Wataru Shioyama, MD, PhD, Toru Oka, MD, PhD, Takako Inoue, MD, PhD, Toru Kumagai, MD, PhD, Masashi Fujita, MD, PhD
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X22000555

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X22000555

Similar Items